Bile acids as drivers and biomarkers of hepatocellular carcinoma

The prevalence of hepatocellular carcinoma (HCC) is rapidly increasing, driven not least in part by the escalating prevalence of non-alcoholic fatty liver disease. Bile acid (BA) profiles are altered in patients with HCC and there is a developing body of evidence from in vitro human cellular models...

Descripción completa

Detalles Bibliográficos
Autores principales: Colosimo, Santo, Tomlinson, Jeremy W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521453/
https://www.ncbi.nlm.nih.gov/pubmed/36185719
http://dx.doi.org/10.4254/wjh.v14.i9.1730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521453/
https://www.ncbi.nlm.nih.gov/pubmed/36185719
http://dx.doi.org/10.4254/wjh.v14.i9.1730

Ejemplares similares